Start with three separate questions.
A peptide quote may include a purity percentage, an amount per unit and a molecular-mass result. Read each against the question it answers: how much of the detected chromatographic signal belongs to the target, how much peptide was measured, and what evidence supports the material’s identity. One strong result cannot replace the other two.
This distinction matters when comparing BPC-157, GHK-Cu, Semax or any other named research material. A brief headed “high purity” still needs a defined content requirement if your purchasing decision depends on the amount received. Keep the requested material, pack configuration and measurement basis together on the order line.
An HPLC area percentage describes a detector signal.
HPLC separates sample components over time. A detector produces peaks, and the report calculates areas under those peaks. A UV area-purity result expresses the target peak’s share of the included detected area under that method. It is not automatically a percentage of the total powder’s weight.
The archived NIST RM 8327 report treats UV area-percent purity and peptide mass purity as separate measurements. Its definitions are a useful method reference, rather than a current certificate for our products. NIST’s archived peptide measurement definitions, pages 1 and 4 (PDF).
Ask which detector conditions and integration rules apply. Request the chromatogram when peak assignment or separation needs review. Keep the method with the reported percentage when comparing two quotes.
A content assay needs a method, units and a reporting basis.
An assay can quantify peptide content, but “assay” alone does not tell you how the number was established. NIST’s 2019 oxytocin comparison examined calibrated HPLC assays, quantitative nuclear magnetic resonance and amino acid analysis. It shows why HPLC used for a content assay should be distinguished from a simple area-percentage calculation. NIST’s peptide quantification comparison.
For procurement, ask whether the result is an amount per unit, a concentration or a mass fraction. Check the units and the reference or calibration used. A stated label amount, total powder weight and measured peptide content should not be treated as interchangeable.
Separate research on angiotensin I compared mass-balance, corrected amino acid analysis and other approaches to assigning peptide purity by mass. Those are method examples, not a promise that any particular analysis was performed on an offered batch. NIST’s study of peptide purity value assignment.
Identity evidence answers “what material is this?”
Mass spectrometry can provide a peptide’s measured molecular mass. Fragmentation analysis can add sequence information. Agilent’s technical reference describes LC/MS mass determination and MS/MS sequence characterisation as distinct analytical steps. Agilent’s peptide characterisation reference.
Ask the laboratory to interpret the observed data against the exact requested identity. Do not read a matching mass as a measured amount per vial, or automatically as complete sequence confirmation. Your technical reviewer should decide which identity evidence fits the specification.
A high area percentage can coexist with a different content result.
Imagine a quotation stating a nominal 10.0 mg per unit. Its test report gives 99.1% HPLC area purity and a separate calibrated assay result of 8.8 mg per tested unit. The area figure describes the target’s share of the included chromatographic signal. The assay describes the amount measured on its stated basis.
Multiplying 10.0 mg by 99.1% does not turn an area-percentage result into a verified content measurement. In this example, review the separate 8.8 mg result against the content requirement actually agreed in the quote. A batch can meet an area-purity criterion and still require further review against a different content criterion.
Define the result you need before comparing the price.
| Requirement | Put in the quote | Review in the report |
|---|---|---|
| Chromatographic purity | Agreed area-purity limit and method. | Area percentage, detector conditions and integration basis. |
| Measured content | Required amount or range, units and reporting basis. | Assay result, method and calibration or reference. |
| Material identity | Exact requested identity and evidence required. | Observed data and the laboratory’s interpretation. |
| Sampling and variation | Which units or samples are assessed; decision rule if needed. | Sample references, sampling basis and reported uncertainty where applicable. |
| Pack configuration | Unit count and agreed contents of each pack. | Match the accepted specification to the supplied unit and pack labels. |
These are purchasing questions, not universal pass limits. Agree suitable criteria with your laboratory and supplier before order acceptance. If a result approaches a limit, ask how measurement uncertainty and the agreed decision rule affect the review.
Make each material and presentation easy to compare.
For BPC-157, keep the full material identity and required amount explicit. For GHK-Cu, ask how the quoted amount is defined. For Semax, specify the requested presentation and content basis rather than assuming a material name defines a finished format. Vials and pen-kit presentations require their own agreed pack details.
Wholesale amounts and available formats are confirmed during enquiry. Use the peptide COA checklist for the wider document review, and the bulk order specification guide for unit counts and packaging. Then request the current wholesale catalogue with your measurement requirements.
Request content & testing details